68727-745 : Vyxeos Intravenous Injection, Powder, Lyophilized, for Suspension

Labeler: Jazz Pharmaceuticals, Inc.
Product Type: Human Prescription Drug
Drug Name:  Vyxeos
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Suspension
Application #: NDA209401
Rev. Date: 

NDC Package Codes:

  • 68727-745-01: 20 ML IN 1 VIAL (68727‑745‑01)
  • 68727-745-02: 40 ML IN 1 CARTON (68727‑745‑02)
  • 68727-745-05: 100 ML IN 1 CARTON (68727‑745‑05)

Active Ingredients:

  • Cytarabine
  • Daunorubicin

Dosage Strength:

  • 100 mg/20mL
  • 44 mg/20mL

Pharmaceutical Classes:

  • Nucleic Acid Synthesis Inhibitors [MoA]
  • Nucleoside Metabolic Inhibitor [EPC]
  • Anthracycline Topoisomerase Inhibitor [EPC]
  • Anthracyclines [CS]
  • Topoisomerase Inhibitors [MoA]


Scan the QR code below to easily reference this data in the future:

NDC 68727-745 QR Code

< Prev: 68727-712Next: 68727-800 >

Note: The MedsChat® NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.